Merck & Co Inc (NYSE:MRK)
$ 129.55 -0.83 (-0.64%) Market Cap: 328.13 Bil Enterprise Value: 358.83 Bil PE Ratio: 143.94 PB Ratio: 8.13 GF Score: 85/100

Q4 2018 Merck & Co Inc Earnings Call Transcript

Feb 01, 2019 / 01:00PM GMT
Release Date Price: $72.9 (+2.71%)
Operator

Good morning. My name is Darla, and I will be your conference operator today. At this time, I would like to welcome everyone to Merck's Fourth Quarter 2018 Sales and Earnings Conference Call. (Operator Instructions)

I would now like to turn the call over to Teri Loxam, SVP, Investor Relations and Global Communications. Please go ahead.

Teri Loxam
Merck & Co., Inc. - Senior VP of IR & Global Communications

Thank you, Darla, and good morning. Welcome to Merck's Fourth Quarter and Full Year 2018 Conference Call.

Today, I'm joined by Ken Frazier, our Chairman and Chief Executive Officer; Rob Davis, our Chief Financial Officer; and Dr. Roger Perlmutter, President of Merck Research Labs, who will each have prepared remarks. In addition, I am joined by Mike Nally, our new Chief Marketing Officer; and Frank Clyburn, our new Chief Commercial Officer, who will both be available for the Q&A portion of the call.

Before I turn the call over to Ken, I'd like to point out a few items. You'll see that we have items in our GAAP results

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot